NEW YORK, March 21 (GenomeWeb News) - Pittsburgh Life Sciences Greenhouse said today it has invested $100,000 in Proteopure, a spinout of Carnegie Mellon University.
Proteopure is developing 2DE preparation kits using spin columns to bind and isolate proteins. It is expected to be commercially available this year.
PLSG is a public/private partnership founded by the University of Pittsburgh, Carnegie Mellon, UPMC Health System, and the Commonwealth of Pennsylvania.